Researchers at Ruhr University Bochum, in collaboration with the Heart and Diabetes Center NRW, have identified that the hepatitis E virus (HEV) undergoes dynamic genetic evolution during the initial weeks of infection. According to a study published in mBio on July 10, 2026, scientists observed recurring mutations in the viral polymerase gene, even within patients who showed low overall genetic diversity in their viral populations.
Early-Stage Viral Dynamics and Genetic Adaptation
While healthy individuals typically clear hepatitis E within weeks, the immune system generally eliminates the viruses within a few weeks. Doctoral student Saskia Janshoff and her team analyzed blood samples from 80 donors to track how the virus adapts shortly after transmission. The findings indicate that the early phase of infection is a period of intense biological activity, characterized by the emergence and disappearance of specific viral variants.
The study highlights a phenomenon known as transcomplementation. Researchers, including Dr. André Gömer, found that some mutated virus variants are unable to replicate independently. However, these defective variants persist by “hitching a ride” on the machinery of intact, healthy viruses present in the same host. This mechanism allows the virus to maintain a diverse population, potentially providing a strategy to evade immune responses or survive antiviral therapy.
Did you know?
The viral polymerase is important for the replication of the hepatitis E virus. Because it is essential for the virus to copy its genetic material, it serves as a primary target for current antiviral medications. Mutations in this specific gene are closely monitored by clinicians to track potential drug resistance.
Implications for Chronic Infection and Treatment
The research provides a new baseline for understanding why some patients, particularly those with compromised immune systems, develop chronic hepatitis E. By documenting the “highly dynamic” nature of the virus in its early stages, the study suggests that the precursors to chronic infection may be established much sooner than previously understood.
Comparing these findings to later stages of infection, the team noted that while the initial diversity is relatively low, the recurrent nature of certain mutations in the polymerase gene suggests these changes are not random. The researchers believe these specific genetic shifts may play a role in how the virus interacts with the host’s immune system, though they emphasize that further investigation is required to confirm the functional benefits of these mutations for the virus.
Future Research and Clinical Pathways
This study was supported by the Federal Ministry of Research, Technology, and Space (grant numbers 01KI2106; 01EK2106A/B) and the German Center for Infection Research. It represents a collaborative effort involving experts from the University of Bielefeld, the HepE-Hub, TWINCORE Hannover, and the Hannover Medical School.
Future work aims to determine how these early genetic mutations influence long-term disease progression. For clinicians, the data highlights the importance of longitudinal sampling—taking multiple samples over time—to visualize the “evolutionary race” between the virus and the host immune system.
Frequently Asked Questions
Why is hepatitis E considered dangerous for some patients?
While most healthy people clear the virus naturally, it can become a chronic, life-threatening condition for individuals with suppressed or compromised immune systems, such as transplant recipients or those undergoing chemotherapy.
What is transcomplementation?
It is a biological mechanism where a defective virus, which cannot replicate on its own, survives and spreads by utilizing the proteins produced by functional, non-defective viruses in the same environment.
How does this study help doctors?
By mapping the early evolution of the virus, researchers are creating a foundation for better diagnostic tools and more effective antiviral therapies that target specific, recurring mutations rather than just the virus as a whole.
Are you interested in the latest advancements in virology and infectious disease research? Subscribe to our newsletter for deep dives into peer-reviewed studies and expert analysis.
Related reading
